With a foundation in cell culture that dates back to 1970, FUJIFILM Biosciences is a global, full spectrum supplier to the life sciences market, providing products and services that assist customers in advancing healthcare initiatives. With an expanding portfolio of applications supported that include life science and discovery research, cell and gene therapy, as well as the large-scale production of biotherapeutics and vaccines, the Company is trusted by researchers and manufacturers worldwide.
For over 50 years, FUJIFILM Biosciences’ Mission has been to empower all who bring medicines and treatments to life with unmatched quality and responsiveness in its products and custom solutions, providing customers with the vital resources needed to enrich human lives through innovative, accessible therapies. The Company’s facilities adhere to both ISO and FDA regulations, with manufacturing facilities that follow cGMP guidelines in the USA, Japan, and the Netherlands, and a media optimization center in China.
All sites prioritize strategies that adhere to the FUJIFILM Sustainability Value Plan 2030 for sustainable growth. FUJIFILM Biosciences is a subsidiary of FUJIFILM Holdings America Corporation reporting to FUJIFILM Holdings Corporation.
For more information, please visit: fujifilmbiosciences.fujifilm.com
FEATURED INSIGHTS
-
Stability Of Supplemented PRIME-XV T Cell CDM At Room Temperature
Gain insight into how a supplemented medium stored at room temperature for up to 72 hours maintained T cell expansion performance, showing consistent viability and marker expression.
-
Predicting The Performance Of Perfusion Media In A Continuous Bioreactor
Small-scale perfusion-mimic models can effectively predict media performance in continuous bioreactors to help optimize cell density, productivity, and scalability for CHO cell lines.
-
Optimize, Automate, And Scale Closed-System MSC Expansion
Efficiently scale your MSC therapy manufacturing with closed systems. Learn how a dual-component media kit streamlines automation, reduces variability, and ensures seamless scale-up with minimal optimization.
-
How Beta-lactams Can Pose A Risk To Your CGTs
Beta-lactam antibiotics pose an invisible contamination risk to CGTs, threatening patient safety and regulatory compliance. Learn the critical steps to mitigate this risk in your raw materials.
-
Freeze, Thaw, And Expand: Scale-Up T Cell Workflow In Chemically Defined Media
A chemically defined T cell workflow improves reproducibility and supports robust expansion in both static and bioreactor scale-up systems, while allowing for the elimination of the post-thaw wash step.
-
Demonstrating Key Processes Of The T Cell Therapy Workflow In Chemically Defined Media
Learn how chemically defined media supports robust cell expansion and function across key T cell therapy workflow steps, including a wash-free cryopreservation and thaw process for simplified scale-up.
-
Human Platelet Lysate (hPL) Improves Expansion Of MSCs
Learn how human platelet lysate significantly improves mesenchymal stromal/stem cell expansion and eliminates the need for plate coating, boosting yield without altering cell phenotype.
-
Scalable Strategies For Intensified Viral Vector Production In HEK293 Cell Culture
Learn a strategy for scalable bioprocessing and media optimization that drives intensified viral vector production. Achieve high cell density, excellent viability, and consistent AAV titers from 50mL to 5L.
-
Chemically Defined HEK293 Viral Feed Boosts Viral Vector Production
Discover how a chemically defined viral feed can boost AAV titers by up to 8-fold, supporting multiple serotypes and both suspension and adherent HEK293 cell lines, simplifying scalability.
CONTACT INFORMATION
FUJIFILM Biosciences
1830 E. Warner Avenue
Santa Ana, CA 92705-5505
UNITED STATES
Phone: 949-261-7800
Fax: 949-261-6522
NEWS
SOLUTIONS
Chemically Defined, Animal Component-Free Medium For T Cell Culture
Learn how you can support robust T cell expansion and transduction without enhancers, while maintaining viability and functionality across systems to enable consistent performance.
-
Explore solutions that support scalable MSC and T cell expansion with optimized media and bioreactor compatibility to enable consistent yields, reduced contamination risk, and streamlined workflows.
-
This xeno- and serum-free media and supplement pairing provides consistent, high-yield expansion of MSCs from various tissue sources while maintaining their critical phenotype.
-
Maximize your viral vector output with a chemically defined medium engineered for high cell density HEK293 perfusion and intensified processes, optimizing efficiency and product integrity.